Globus Medical (BSP:G2ME34) Cyclically Adjusted PB Ratio: (As of Aug. 11, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:G2ME34 Globus Medical Inc BSP:G2ME34
26 GF Score
Price R$52.00
GF Value R$58.52
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Globus Medical Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Globus Medical  (BSP:G2ME34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Globus Medical Cyclically Adjusted PB Ratio Related Terms


Globus Medical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Globus Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Cyclically Adjusted PB Ratio Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.89 5.96 3.62 4.77 4.31

Globus Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.13 2.93 4.31 4.06 3.58

BSP:G2ME34 vs PODD, BRKR, GKOS: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted PB Ratio falls into.


BSP:G2ME34
26GF Score
Globus Medical Inc BSP:G2ME34
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Globus Medical's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Globus Medical's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=177.858/333.9520*333.9520
=177.858

Current CPI (Jun. 2026) = 333.9520.

Globus Medical Quarterly Data

Book Value per Share CPI Adj_Book
201609 27.508 241.428 38.050
201612 29.092 241.432 40.240
201703 28.284 243.801 38.743
201706 30.983 244.955 42.240
201709 30.402 246.819 41.135
201712 32.991 246.524 44.691
201803 34.654 249.554 46.374
201806 42.113 251.989 55.811
201809 47.623 252.439 63.001
201812 46.705 251.233 62.083
201903 48.006 254.202 63.067
201906 50.106 256.143 65.327
201909 55.483 256.759 72.164
201912 57.665 256.974 74.939
202003 67.911 258.115 87.864
202006 70.956 257.797 91.917
202009 77.559 260.280 99.512
202012 77.717 260.474 99.640
202103 88.061 264.877 111.026
202106 81.830 271.696 100.580
202109 89.402 274.310 108.840
202112 96.976 278.802 116.159
202203 87.338 287.504 101.448
202206 86.225 296.311 97.178
202209 92.659 296.808 104.255
202212 96.664 296.797 108.765
202303 99.402 301.836 109.979
202306 95.924 305.109 104.992
202309 147.082 307.789 159.584
202312 143.683 306.746 156.427
202403 144.626 312.332 154.637
202406 158.226 314.175 168.186
202409 165.819 315.301 175.628
202412 185.460 315.605 196.241
202503 173.908 319.799 181.604
202506 176.401 322.561 182.630
202509 175.260 324.800 180.198
202512 221.534 324.054 228.301
202603 182.419 330.213 184.485
202606 177.858 333.952 177.858

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Globus Medical (BSP:G2ME34) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of R$52.00 is trading 11.1% below its estimated GF Value™ of R$58.52. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for BSP:G2ME34:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: R$58.52 vs. price of R$52.00 (11.1% below fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the BSP:G2ME34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
26GF Score

Get the complete analysis for BSP:G2ME34

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.00
Price
R$58.52
GF Value